The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Elevated cholesterol and decreased sterol carrier protein-2 in peroxisomes from AS-30D hepatoma compared to normal rat liver.
H T Lyons; A Kharroubi; N Wolins; S Tenner; R F Chanderbhan; G Fiskum; R P Donaldson (Profiled Author: Gary M Fiskum)
Department of Biological Sciences, George Washington University, Washington, D.C. 20052.
Archives of biochemistry and biophysics 1991;285(2):238-45.
Peroxisomes were isolated from AS-30D hepatoma and compared to normal rat liver cells for the purpose of investigating the cholesterol accumulation in the hepatoma cells. Cholesterol was found to be approximately 10-fold higher relative to protein in AS-30D peroxisomes as compared to peroxisomes from normal liver. The peroxisomes from the hepatoma cells were found to be more stable; catalase was not released from these peroxisomes during isolation or osmotic shock of the peroxisomal fraction. The elevated cholesterol level may stabilize the peroxisomal membrane. Sterol carrier protein-2 (SCP-2) levels were measured using a radioimmunoassay (RIA), which indicated the highest concentration of SCP-2 to be in peroxisomes. Hepatoma peroxisomes had a lower concentration of SCP-2 (2.5 micrograms/mg) than normal liver peroxisomes (8 micrograms/mg). Approximately half of all SCP-2 detected was found to be soluble in both hepatoma and normal rat liver cells. Immunoblots from both rat liver and AS-30D fractions demonstrated the presence of the 14-kDa form of SCP-2. The liver fractions also had a 57-kDa immunoreactive protein, which was barely detectable in the AS-30D fractions. The low abundance of the high molecular weight form of SCP-2 from hepatoma peroxisomes and the lower amounts of SCP-2 detected in the AS-30D peroxisomes may be related to the accumulation of cholesterol in the cells.
1 Originating Grant
FISKUM, GARY M
1 July 1983 - 30 June 1992
NATIONAL CANCER INSTITUTE
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
G V Vahouny; R Chanderbhan; P Stewart; R Tombes; E Keyeyune-Nyombi; G Fiskum; T J ScallenBiochimica et biophysica acta 1985;834(3):324-30.
G V Vahouny; P Dennis; R Chanderbhan; G Fiskum; B J Noland; T J ScallenBiochemical and biophysical research communications 1984;122(2):509-15.
A L Ellis; C E Munger; R T Bunch; K E Woods; J K Randolph; L Boise; P S Swerdlow; L A Zwelling; M Hinds; S YanovichBiochemical pharmacology 1992;43(2):331-42.
Appears in this Publication
Author of this Publication